Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

BioLineRx finds first Big Pharma collaborator in Novartis, which takes equity stake

Executive Summary

In a multi-year deal, Novartis Pharma AG received exclusive rights of first negotiation to develop and commercialize up to three programs in BioLineRx Ltd.’s pipeline sourced from Israeli partners. Novartis took a 12.8% stake in BioLineRx for $10mm (5mm ADSs at $2).
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • R&D and Marketing (Licensing)

Related Companies